Telix Pharmaceuticals Limited
NASDAQ:TLX · NASDAQ Global Select
+$0.12 today
Vol 0.08M · Avg 0.20M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-38.44%
Period High
$16.92
Period Low
$6.41
Latest
$10.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.89B
Belite Bio, Inc
NASDAQ:BLTE
$5.85B
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
$5.36B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$5.28B
Celcuity Inc.
NASDAQ:CELC
$4.19B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.67B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.27B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.70B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.96B
What is the latest TLX filing?
The latest filing shown is 6-K dated May 21, 2026.
How many recent filings does TLX have?
Intrinsic Alpha currently shows 20 recent filings for TLX.
Explore More
Continue the stock analysis
Jump to another research area for this company.